1. Home
  2. MDGL vs WAY Comparison

MDGL vs WAY Comparison

Compare MDGL & WAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • WAY
  • Stock Information
  • Founded
  • MDGL 2011
  • WAY 1999
  • Country
  • MDGL United States
  • WAY United States
  • Employees
  • MDGL N/A
  • WAY N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • WAY
  • Sector
  • MDGL Health Care
  • WAY
  • Exchange
  • MDGL Nasdaq
  • WAY Nasdaq
  • Market Cap
  • MDGL 6.8B
  • WAY 6.1B
  • IPO Year
  • MDGL N/A
  • WAY 2024
  • Fundamental
  • Price
  • MDGL $295.36
  • WAY $39.11
  • Analyst Decision
  • MDGL Strong Buy
  • WAY Strong Buy
  • Analyst Count
  • MDGL 10
  • WAY 12
  • Target Price
  • MDGL $420.63
  • WAY $41.45
  • AVG Volume (30 Days)
  • MDGL 374.9K
  • WAY 1.4M
  • Earning Date
  • MDGL 05-01-2025
  • WAY 04-30-2025
  • Dividend Yield
  • MDGL N/A
  • WAY N/A
  • EPS Growth
  • MDGL N/A
  • WAY N/A
  • EPS
  • MDGL N/A
  • WAY 0.15
  • Revenue
  • MDGL $317,383,000.00
  • WAY $975,192,000.00
  • Revenue This Year
  • MDGL $264.55
  • WAY $8.21
  • Revenue Next Year
  • MDGL $67.21
  • WAY $9.89
  • P/E Ratio
  • MDGL N/A
  • WAY $255.04
  • Revenue Growth
  • MDGL N/A
  • WAY 18.25
  • 52 Week Low
  • MDGL $200.08
  • WAY $20.26
  • 52 Week High
  • MDGL $377.46
  • WAY $48.11
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 40.64
  • WAY N/A
  • Support Level
  • MDGL $287.46
  • WAY N/A
  • Resistance Level
  • MDGL $307.54
  • WAY N/A
  • Average True Range (ATR)
  • MDGL 16.74
  • WAY 0.00
  • MACD
  • MDGL -2.04
  • WAY 0.00
  • Stochastic Oscillator
  • MDGL 12.84
  • WAY 0.00

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About WAY Waystar Holding Corp. Common Stock

Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.

Share on Social Networks: